Acute chest pain (ACP) is a common presentation in clinical practice, often posing diagnostic challenges due to its diverse etiology. This article aims to provide a comprehensive guide to evaluating and managing ACP effectively.
Initial assessment should focus on history and physical examination, with emphasis on pain characteristics, associated symptoms, and risk factors for coronary artery disease. Electrocardiogram and cardiac biomarkers are essential for early detection of acute coronary syndromes. Additional diagnostic tests, such as chest radiograph or computed tomography, may be necessary based on clinical suspicion of non-cardiac causes.
Risk stratification tools, like the HEART score or TIMI risk score, can aid in decision-making. These tools incorporate clinical variables to predict major adverse cardiac events, guiding the need for hospital admission or further diagnostic testing.
Management strategies should be tailored to the underlying cause. In suspected acute coronary syndrome, immediate revascularization or anti-ischemic therapy may be warranted. For non-cardiac causes, appropriate management varies from analgesia for musculoskeletal pain to antibiotics for pneumonia, or even surgery for aortic dissection.
Patients discharged after an ACP episode should be closely followed up. Lifestyle modification, pharmacotherapy for risk factor control, and patient education are key components of secondary prevention.
ACP evaluation and management require a systematic approach, incorporating clinical assessment, risk stratification, and tailored treatment strategies. By adopting this approach, clinicians can ensure appropriate care for patients presenting with this common, yet often complex, clinical scenario.
1.
FDA Expands Use of T-DXd in Early HER2+ Breast Cancer
2.
younger kidney cancer survivors are more susceptible to heart problems.
3.
Gene therapy for glioblastoma is effectively created by researchers.
4.
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?
5.
Patellar Resurfacing in Total Knee Replacement; Patient Messaging Trends
1.
Hematopoietic Aging and Long-Term Disease Risk: Mechanisms, Clinical Impact, and Emerging Therapeutic Strategies
2.
Clinical Guidance for Survivorship-Focused Cancer Care
3.
Transformative Insights in Oncology in Daily Practice
4.
Revolutionizing Cancer Treatment with Trilaciclib: How a New Drug is Transforming Outcomes
5.
How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care?
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
2.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
3.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation